Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Tapering Protocol for Alprazolam

Introduction to Tapering

  • The Centers for Disease Control and Prevention recommends a gradual taper of alprazolam with a reduction of 25% of the daily dose every 1-2 weeks to minimize withdrawal symptoms and ensure patient safety 1
  • The Mayo Clinic suggests beginning with patient education about the risks of continued alprazolam use and benefits of tapering 2
  • The American Academy of Family Physicians recommends an initial taper: Reduce total daily dose by 0.25 mg (25% of daily 1 mg dose) every 1-2 weeks 1
  • A sample taper schedule is:

    Week Morning Dose Evening Dose Total Daily Dose
    1-2 0.5 mg 0.25 mg 0.75 mg
    3-4 0.25 mg 0.25 mg 0.5 mg
    5-6 0.25 mg 0 mg 0.25 mg
    7-8 0 mg 0 mg 0 mg

    Monitoring and Adjunctive Treatments

  • The Mayo Clinic Proceedings recommends assessing for withdrawal symptoms at each visit and watching for both acute withdrawal and protracted withdrawal 5
  • The Mayo Clinic suggests considering non-pharmacological interventions to manage anxiety during taper, such as cognitive-behavioral therapy and integrative strategies like relaxation techniques and physical activity 2
  • The American Academy of Family Physicians recommends considering pharmacological adjuncts like buspirone for anxiety/insomnia and clonidine for physical symptoms 3, 4

Common Pitfalls to Avoid

  • The FDA, as reported by the Mayo Clinic Proceedings, warns against abrupt discontinuation due to serious withdrawal risks 5
  • The Centers for Disease Control and Prevention recommends avoiding concurrent use of other CNS depressants during the taper period 1
  • The Mayo Clinic suggests addressing the underlying reasons for alprazolam abuse while managing the taper 2

Tapering Alprazolam

Introduction to Tapering

  • The American College of Physicians and other guideline societies recommend tapering alprazolam by 25% of the total daily dose every 1-2 weeks, targeting an 8-week taper to complete discontinuation, while monitoring closely for withdrawal symptoms and providing adjunctive support, with a strength of evidence level of moderate to high 6

Cardiovascular Considerations

  • Tachycardia is a common withdrawal symptom, occurring in 12.2% of patients, according to the Mayo Clinic Proceedings 6

Non-Pharmacological Interventions

  • Cognitive-behavioral therapy (CBT) during taper significantly increases success rates, with weekly 90-120 minute group sessions demonstrating feasibility and effectiveness, as reported in the Mayo Clinic Proceedings 7

Expected Outcomes

  • Standardized advice from the physician combined with a structured tapering schedule achieves discontinuation in approximately 45% of patients at 12 months, with most patients experiencing stable or improved anxiety after successful taper, as noted in the Mayo Clinic Proceedings 6, 8